跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xenteri - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Xenteri
Approved
STANDARD
Xenteri
Akriti Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d01728146521a0ef
Company
Akriti Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
d01728146521a0ef
Drug Approval Philippines Name
Xenteri
Product Name
Xenteri
Registration Number
DRP-11128-02
Brand Name
Xenteri
Generic Name
Cetirizine dihydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg
Manufacturer
Akriti Pharmaceuticals Pvt. Ltd.
Importer
Aglobal Care, Inc.
Distributor
Bellus Life Solutions, Inc
Issuance Date
27 June 2022
Expiry Date
29 September 2026
Pharmacologic Category
Antihistamine
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d01728146521a0ef
Type
Standard
Back to Philippines FDA Approvals